Quick Links

COVID-19

Researchers from the Seattle Flu Study and the University of Washington are teaming up with Apple to understand how everyday devices, like an Apple Watch or iPhone, can be used to predict illnesses like COVID-19. Participant Eligibility - Live in the greater Seattle area - Age 22+ - May...

The ACTIV-2 trial is an adaptive design study that prioritizes the development of promising new therapeutics to expand our treatments of COVID-19. We're testing different medicines to see if they're safe and can help adults recover more quickly. Teams of dedicated researchers want to ensure...

This is a study to determine if a drug called fluvoxamine can be used early in the course of the COVID-19 infection to prevent more serious complications, like shortness of breath.  This study is fully-remote, which means that there is no face-to-face contact; study materials including study drug...

This study is testing whether a drug called Remdesivir can reduce symptoms and the need for hospitalization in individuals with COVID-19. Remdesivir has been shown to help patients recover faster in the hospital, and this study will determine whether it is also beneficial in less-sick...

The purpose of this pilot study is to record the daily human activities, and to develop predictive models of physical activity. We hope this study will enable researchers to test and validate new technologies that may subsequently be used to study and inform researchers and...

SITE PARTNERS
uw-footer